USANA Health Sciences, Inc. (NYSE:USNA) Holdings Raised by Rhumbline Advisers

Rhumbline Advisers increased its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 39.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,390 shares of the company’s stock after purchasing an additional 14,068 shares during the period. Rhumbline Advisers owned 0.26% of USANA Health Sciences worth $1,773,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Creative Planning bought a new position in shares of USANA Health Sciences in the third quarter valued at $394,000. Harbor Capital Advisors Inc. boosted its position in shares of USANA Health Sciences by 44.1% in the third quarter. Harbor Capital Advisors Inc. now owns 8,859 shares of the company’s stock worth $336,000 after buying an additional 2,713 shares during the period. KBC Group NV grew its stake in USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after acquiring an additional 519 shares in the last quarter. Royce & Associates LP lifted its position in shares of USANA Health Sciences by 22.2% in the third quarter. Royce & Associates LP now owns 33,143 shares of the company’s stock worth $1,257,000 after purchasing an additional 6,031 shares in the last quarter. Finally, Quest Partners LLC purchased a new stake in shares of USANA Health Sciences in the third quarter worth approximately $250,000. 54.25% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. DA Davidson dropped their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

Insider Buying and Selling at USANA Health Sciences

In related news, CEO Jim Brown sold 5,000 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $29.47, for a total value of $147,350.00. Following the transaction, the chief executive officer now directly owns 15,716 shares in the company, valued at approximately $463,150.52. This trade represents a 24.14 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

USANA Health Sciences Stock Performance

NYSE:USNA opened at $29.72 on Wednesday. The company has a market capitalization of $566.44 million, a P/E ratio of 10.50, a P/E/G ratio of 0.93 and a beta of 0.87. The stock’s 50 day moving average price is $33.34 and its 200 day moving average price is $36.41. USANA Health Sciences, Inc. has a 52 week low of $27.71 and a 52 week high of $50.32.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million. As a group, sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.